{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:23:03Z","timestamp":1787779383245,"version":"build-2784847793"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10549"],"award-info":[{"award-number":["24K10549"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacl.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:49:29Z","timestamp":1781542169000},"page":"1683-1690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effects"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4842-7492","authenticated-orcid":false,"given":"Ayano","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-4370","authenticated-orcid":false,"given":"Naoya","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiyori","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0954-0224","authenticated-orcid":false,"given":"Chihiro","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetta","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Miyabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-1448","authenticated-orcid":false,"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-1452","authenticated-orcid":false,"given":"Kazuya","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-8070","authenticated-orcid":false,"given":"Katsuyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-9901","authenticated-orcid":false,"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jacl.2026.06.009_bib1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacl.2026.06.009_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/L20-0327","article-title":"Chylomicronemia from GPIHBP1 autoantibodies successfully treated with rituximab: a case report","volume":"173","author":"Lutz","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jacl.2022.10.005","article-title":"A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease","volume":"17","author":"Nozue","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.06.009_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2018.09.039","article-title":"An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome","volume":"487","author":"Miyashita","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jacl.2017.10.022","article-title":"An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum","volume":"12","author":"Miyashita","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"e12095","DOI":"10.7554\/eLife.12095","article-title":"The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain","volume":"5","author":"Mysling","year":"2016","journal-title":"Elife"},{"issue":"36","key":"10.1016\/j.jacl.2026.06.009_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211136119","article-title":"A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism","volume":"119","author":"Young","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1194\/jlr.M072462","article-title":"Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL","volume":"58","author":"Hu","year":"2017","journal-title":"J Lipid Res"},{"issue":"26","key":"10.1016\/j.jacl.2026.06.009_bib9","doi-asserted-by":"crossref","first-page":"E6020","DOI":"10.1073\/pnas.1806774115","article-title":"A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase","volume":"115","author":"Kristensen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jacl.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacl.2020.01.012","article-title":"Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies","volume":"14","author":"Ashraf","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5551\/jat.63348","article-title":"Anti-GPIHBP1 antibody-positive autoimmune hyperchylomicronemia and immune thrombocytopenia","volume":"30","author":"Tanaka","year":"2023","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"10.1016\/j.jacl.2026.06.009_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ped.14154","article-title":"Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies","volume":"62","author":"Imai","year":"2020","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacl.2018.10.004","article-title":"GPIHBP1 autoantibody syndrome during interferon \u03b21a treatment","volume":"13","author":"Eguchi","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2026.06.009_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaccas.2019.11.052","article-title":"A woman with hypertriglyceridemia who acquired antibody against GPIHBP1","volume":"2","author":"Hirano","year":"2020","journal-title":"JACC Case Rep"},{"issue":"4","key":"10.1016\/j.jacl.2026.06.009_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.alit.2022.05.001","article-title":"Development of hypertriglyceridemia due to GPIHBP1 autoantibodies prior to clinical diagnosis of systemic lupus erythematosus in a 14-year-old girl","volume":"71","author":"Kunitsu","year":"2022","journal-title":"Allergol Int"},{"issue":"4","key":"10.1016\/j.jacl.2026.06.009_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2004.10.023","article-title":"Severe hypertriglyceridemia in a patient with lupus","volume":"118","author":"Blom","year":"2005","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.jacl.2026.06.009_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.06.009_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol"},{"issue":"12","key":"10.1016\/j.jacl.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:07:20Z","timestamp":1787778440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1933287426004010"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.06.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}